Related Experiment Video
Updated: Jul 17, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
Mechanisms of inhibited liver tissue repair in toxicant challenged type 2 diabetic rats
Sharmilee P Sawant1, Ankur V Dnyanmote, Harihara M Mehendale
1Department of Toxicology, College of Pharmacy, The University of Louisiana at Monroe, 700 University Avenue, Sugar Hall #306, Monroe, LA 71209-0470, USA.
Abstract:
Liver injury initiated by non-lethal doses of CCl(4) and thioacetamide (TA) progresses to hepatic failure and death of type 2 diabetic (DB) rats due to failed advance of liver cells from G(0)/G(1) to S-phase and inhibited tissue repair. Objective of the present study was to investigate cellular signaling mechanisms of failed cell division in DB rats upon hepatotoxicant challenge. In CCl(4)-treated non-diabetic (non-DB) rats, increased IL-6 levels, sustained activation of extracellular regulated kinases 1/2 (ERK1/2) MAPK, and sustained phosphorylation of retinoblastoma protein (p-pRB) via cyclin D1/cyclin-dependent kinase (cdk) 4 and cyclin D1/cdk6 complexes stimulated G(0)/G(1) to S-phase transition of liver cells. In contrast to the non-DB rats, CCl(4) administration led to lower plasma IL-6, decreased ERK1/2 activation, lower cyclin D1, and cdk 4/6 expression resulting in decreased p-pRB and inhibition of liver cell division in the DB rats. Furthermore, higher TGFbeta1 expression and p21 activation may also contribute to decreased p-pRB in DB rats compared to non-DB rats. Similarly, after TA administration to DB rats, down-regulation of cyclin D1 and p-pRB leads to markedly decreased advance of liver cells from G(0)/G(1) to S-phase and tissue repair compared to the non-DB rats. Hepatic ATP levels did not differ between the DB and non-DB rats obviating its role in failed tissue repair in the DB rats. In conclusion, decreased p-pRB may contribute to blocked advance of cells from G(0)/G(1) to S-phase and failed cell division in DB rats exposed to CCl(4) or TA, leading to progression of liver injury and hepatic failure.
Insights
Type 2 diabetes impairs liver cell division and repair after injury, leading to hepatic failure. This is due to reduced signaling pathways like ERK1/2 and retinoblastoma protein (pRB) phosphorylation in diabetic rats.
Area of Science:
- Hepatology
- Cellular Biology
- Diabetology
Background:
- Liver injury from toxins like carbon tetrachloride (CCl4) and thioacetamide (TA) can cause hepatic failure, particularly in type 2 diabetic (DB) individuals.
- Diabetic rats exhibit failed liver cell division and tissue repair following non-lethal doses of hepatotoxicants, progressing to fatal hepatic failure.
Purpose of the Study:
- To investigate the cellular signaling mechanisms underlying failed cell division in DB rats after hepatotoxicant challenge.
- To compare the molecular responses to CCl4 and TA in diabetic versus non-diabetic rats regarding cell cycle progression and tissue repair.
Main Methods:
- Comparative analysis of liver cell signaling pathways in CCl4- and TA-treated diabetic (DB) and non-diabetic (non-DB) rats.
- Measurement of key proteins and signaling molecules including IL-6, ERK1/2 MAPK, cyclin D1, cdk4/6, p-pRB, TGFbeta1, p21, and hepatic ATP levels.
Main Results:
- Non-DB rats showed increased IL-6, sustained ERK1/2 activation, and p-pRB phosphorylation, promoting cell cycle progression (G0/G1 to S-phase).
- DB rats exhibited lower IL-6, decreased ERK1/2 activation, reduced cyclin D1/cdk4/6 expression, and consequently, lower p-pRB, inhibiting liver cell division.
- Higher TGFbeta1 and p21 activation in DB rats may further contribute to decreased p-pRB. Hepatic ATP levels were comparable between groups.
Conclusions:
- Decreased retinoblastoma protein (pRB) phosphorylation is a key factor in blocking liver cell cycle progression from G0/G1 to S-phase in DB rats exposed to CCl4 or TA.
- This impaired cell division and tissue repair in DB rats contributes to the progression of liver injury and eventual hepatic failure.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Chronic Pancreatitis II: Pathophysiology

